<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>The Journal of Gene Medicine via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The Journal of Gene Medicine' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=The+Journal+of+Gene+Medicine&t=The+Journal+of+Gene+Medicine&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 09:43:48 +0100</lastBuildDate>
        <item>
            <title>Lentiviral vector followed by protein immunisation breaks tolerance against the self‐antigen Her1 and results in lung cancer immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5615650&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2606</link>
            <description>ConclusionsThe ability of this vaccine protocol to break both T cell and B cell tolerance to a self‐antigen likely explains its effectiveness. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615650</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615650</guid>        </item>
        <item>
            <title>Expression levels of the PiT2 receptor explain, in part, the gestational age‐dependent alterations in transduction efficiency following in Utero retroviral‐mediated gene transfer</title>
            <link>http://www.medworm.com/index.php?rid=5615649&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2607</link>
            <description>ConclusionThe present studies explain the age‐related differences we previously observed in transduction efficiency following in utero GT. They also suggest it may be possible to achieve relatively selective GT to specific tissues by performing in utero GT when levels of PiT2 are maximal in the desired target organ. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615649</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615649</guid>        </item>
        <item>
            <title>Electric pulses augment reporter gene expression in the beating heart</title>
            <link>http://www.medworm.com/index.php?rid=5615648&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2603</link>
            <description>AbstractGene therapy of the heart has been attempted in a number of clinical trials with the injection of naked DNA but quantitative information on myocellular transfection rates is not available. The aim of our study was to quantify the efficacy of electropulsing protocols that differ in pulse duration and number to stimulate transfection of cardiomyocytes and to determine the impact on myocardial integrity.Reporter plasmid for constitutive expression of green fluorescent protein (GFP) was injected into the left ventricle of beating hearts of adult, male Lewis rats. Four electrotransfer protocols consisting of repeated long pulses [8 × 20‐msec], trains of short pulses [8 trains of either 60 or 80 × 100‐µsec], or their combination, were compared to control procedures concern...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615648</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615648</guid>        </item>
        <item>
            <title>Chimeric antigen receptors for T cell immunotherapy: current understanding and future direction</title>
            <link>http://www.medworm.com/index.php?rid=5615647&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2604</link>
            <description>ConclusionIn conclusion CAR modified T cell therapy is a highly promising treatment for cancer having already demonstrated both promising pre‐clinical and clinical results. However, further modification and additional clinical trials will need to be conducted to ultimately optimize the anti‐tumor efficacy of this approach. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615647</comments>
            <pubDate>Thu, 19 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615647</guid>        </item>
        <item>
            <title>CD40‐targeted adenoviral cancer vaccines: the long and winding road to the clinic</title>
            <link>http://www.medworm.com/index.php?rid=5575513&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1648</link>
            <description>SummaryThe ability of Dendritic Cells (DC) to orchestrate innate and adaptive immune responses has been exploited to develop potent anti‐cancer immunotherapies. Recent clinical trials exploring the efficacy of ex vivo modified autologous DC‐based vaccines have reported some promising results. However, in vitro generation of autologous DC for clinical administration, their loading with tumor associated antigens (TAA) and their activation, is laborious and expensive, and, due to interindividual variability in the personalized vaccines, poorly standardized. An attractive alternative approach is to load resident DC in vivo by targeted delivery of TAA, using viral vectors and activating them simultaneously. To this end we have constructed genetically modified Adenoviral (Ad) vectors and bis...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575513</comments>
            <pubDate>Sat, 07 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575513</guid>        </item>
        <item>
            <title>Antitumor effect of chondroitin sulfate‐coated ternary GM‐CSF plasmid complex for ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=5575512&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1647</link>
            <description>ConclusionsThese findings suggest that GM‐CSF/PEI coated with 10‐kilodalton chondroitin sulfate has potential for use in gene therapy of ovarian cancer. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575512</comments>
            <pubDate>Sat, 07 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575512</guid>        </item>
        <item>
            <title>Oligonucleotide‐mediated gene editing is underestimated in cells expressing mutated GFP, and is positively associated with target protein expression</title>
            <link>http://www.medworm.com/index.php?rid=5575511&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1639</link>
            <description>ConclusionsOur data establish that ssODN‐mediated gene editing is underestimated in cultured mammalian cells expressing non‐fluorescent mutated EGFP, because of variable expression of this mEGFP target gene in the cell population. This conclusion was endorsed by studies in HEK293T‐mEGFP and HepG2‐mEGFP cells. We infer that oligonucleotide‐directed editing of endogenous genes is feasible, particularly for those transcriptionally active. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575511</comments>
            <pubDate>Sat, 07 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575511</guid>        </item>
        <item>
            <title>Intrathymic injection of lentiviral vector curtails the immune response in the periphery of normal mice</title>
            <link>http://www.medworm.com/index.php?rid=5575510&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1650</link>
            <description>Discussion: Our results show that injection of the LvHA lentiviral vector significantly curbed the immune response to the same antigen in the periphery. Increased selection of HA‐specific regulatory T cells and negative selection of HA‐specific CD8+ T‐cell precursors may explain the results. Our results establish the feasibility of IT injections of lentiviral vectors to manipulate T‐cell tolerance in the thymus of normal mice, for basic and pre‐clinical research. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575510</comments>
            <pubDate>Sat, 07 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575510</guid>        </item>
        <item>
            <title>CCL19 (ELC) improves TH1‐polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model</title>
            <link>http://www.medworm.com/index.php?rid=5575516&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1651</link>
            <description>ConclusionsCCL19 is able to induce a TH‐1 polarization of the anti Her2/neu immune response which can be further amplified by GM‐CSF. Clinical use of a pDNA(Her2/neu‐CCL19 ± GM‐CSF) vaccine might be promising in Her2/neu + breast cancer in the clinical situation of minimal residual disease. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575516</comments>
            <pubDate>Fri, 06 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575516</guid>        </item>
        <item>
            <title>CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the RPE of choroideremia mice</title>
            <link>http://www.medworm.com/index.php?rid=5575515&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1652</link>
            <description>ConclusionsLentiviral CHM/REP1 cDNA transgene rescues the prenylation defect in CHM mouse RPE and thus could be used to restore REP1 activity in the RPE of CHM patients. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575515</comments>
            <pubDate>Fri, 06 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575515</guid>        </item>
        <item>
            <title>Enhanced intracellular delivery and multi‐target gene silencing triggered by tripodal RNA structures</title>
            <link>http://www.medworm.com/index.php?rid=5575514&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1653</link>
            <description>ConclusionsOur data provide the example of synthetic multifunctional RNA structures that enable multiple gene interference in mammalian cells, which could become powerful tools for the efficient combinatorial iRNA strategy. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575514</comments>
            <pubDate>Fri, 06 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575514</guid>        </item>
        <item>
            <title>Endothelium‐specific over expression of human VEGF‐D in mice leads to increased tumor frequency and a reduced lifespan</title>
            <link>http://www.medworm.com/index.php?rid=5633819&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2608</link>
            <description>ConclusionsIt is concluded that targeted unregulated long‐term expression of hVEGF‐D in endothelium may not be useful and reduces life span of the transgenic mice. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633819</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633819</guid>        </item>
        <item>
            <title>A syringe‐focused ultrasound device for simultaneous injection of DNA and gene transfer</title>
            <link>http://www.medworm.com/index.php?rid=5623736&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1633</link>
            <description>ConclusionsThis new technique provides a simple, safe and efficient nonviral gene delivery approach in skeletal muscle and shows promising applications for gene therapy of human disease, such as Alzheimer's disease. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623736</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623736</guid>        </item>
        <item>
            <title>Pro‐opiomelanocortin gene delivery suppresses the growth of established Lewis lung carcinoma through a melanocortin‐1 receptor‐independent pathway</title>
            <link>http://www.medworm.com/index.php?rid=5623735&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1625</link>
            <description>ConclusionsThese results support the existence of an MC‐1R‐independent pathway for POMC gene therapy, which further expands the therapeutic spectrum of POMC therapy for multiple types of cancer. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623735</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623735</guid>        </item>
        <item>
            <title>Baculovirus‐mediated vascular endothelial growth factor‐DΔNΔC gene transfer induces angiogenesis in rabbit skeletal muscle</title>
            <link>http://www.medworm.com/index.php?rid=5623734&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1637</link>
            <description>ConclusionsWe show the first evidence of biologically significant baculoviral gene transfer in skeletal muscle of NZW rabbits using VEGF‐DΔNΔC as a therapeutic transgene. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623734</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623734</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5623733&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2602</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623733</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623733</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=5623732&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2590</link>
            <description>No abstract is available for this article. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623732</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623732</guid>        </item>
        <item>
            <title>Pro‐opiomelanocortin gene delivery suppresses the growth of established Lewis lung carcinoma through Melanocortin‐1 receptor‐independent pathway</title>
            <link>http://www.medworm.com/index.php?rid=5481665&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1625</link>
            <description>ConclusionsThese results support the existence of an MC‐1R‐independent pathway for POMC gene therapy, which further expands the therapeutic spectrum of POMC therapy for multiple types of cancer. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481665</comments>
            <pubDate>Tue, 06 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5481665</guid>        </item>
        <item>
            <title>Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect</title>
            <link>http://www.medworm.com/index.php?rid=5615646&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.2605</link>
            <description>AbstractDirect vaccination with messenger RNA (mRNA) encoding tumor antigens is a novel and promising approach in cancer immunotherapy. CureVac's mRNA vaccines contain free and protamine‐complexed mRNA. Such two‐component mRNA vaccines support both: antigen expression and immune stimulation. These self‐adjuvanting RNA vaccines, administered intradermaly without any additional adjuvant, induce a comprehensive balanced immune response, comprising antigen specific CD4+ T cells, CD8+ T cells and B cells. The balanced immune response results in a strong anti‐tumor effect and complete protection against antigen positive tumor cells. This tumor inhibition elicited by mRNA vaccines is due to the concerted action of different players. After just two intradermal vaccinations we observe multi...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615646</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615646</guid>        </item>
        <item>
            <title>EphrinA1‐EphA2 interaction‐mediated apoptosis and Flt3L‐induced immunotherapy inhibits tumor growth in a breast cancer mouse model</title>
            <link>http://www.medworm.com/index.php?rid=5575509&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1649</link>
            <description>ConclusionsThe results indicating induction of apoptosis and inhibition of mammary tumor growth show the potential therapeutic benefits of HAd‐EphrinA1‐Fc. In combination with HAd‐Flt3L, this represents a promising strategy to effectively induce mammary tumor regression by HAd vector‐based therapy. Copyright © 2012 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5575509</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5575509</guid>        </item>
        <item>
            <title>Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy</title>
            <link>http://www.medworm.com/index.php?rid=5541611&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1620</link>
            <description>ConclusionsThe ARR2PB‐PNP/Fludara system induced massive tumor cell death and a prolonged life span without systemic cytotoxicity; therefore, it might be a more attractive strategy for suicide gene therapy of prostate cancer. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541611</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5541611</guid>        </item>
        <item>
            <title>RGD peptide‐modified adenovirus expressing hepatocyte growth factor and X‐linked inhibitor of apoptosis improves islet transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5541610&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1626</link>
            <description>ConclusionsThese results indicated that ex vivo transduction of islets with RGD‐Adv‐hHGF‐hXIAP decreased apoptotic islet cell death and improved islet revascularization, and eventually might improve the outcome of human islet transplantation. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541610</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5541610</guid>        </item>
        <item>
            <title>High‐capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product‐directed CD8 T‐cell responses</title>
            <link>http://www.medworm.com/index.php?rid=5541609&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1629</link>
            <description>ConclusionsDe novo expression of viral genes from ΔE1Ad vector genomes restricts the multispecificity of transgene product‐specific CTLs by immunodominance effects. HC‐Ad vectors devoid of Ad genes are favorable for the induction of both multispecific CD8 T‐cell responses and high antibody responses. Our results suggest the deletion of Ad genes as an important means for developing potent Ad‐based vectored vaccines. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541609</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5541609</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5541608&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1642</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541608</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5541608</guid>        </item>
        <item>
            <title>Editorial Board Article</title>
            <link>http://www.medworm.com/index.php?rid=5541607&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1640</link>
            <description>No abstract is available for this article. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541607</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5541607</guid>        </item>
        <item>
            <title>The assessment of adeno‐associated vectors as potential intrinsic treatments for brainstem axon regeneration</title>
            <link>http://www.medworm.com/index.php?rid=5436144&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1628</link>
            <description>ConclusionsSerotype 2 AAV‐EGFP enabled easy visualization of brainstem axon regeneration. Rigorous models of axonal injury (complete transection and cell implantation), should be used in combination with AAV‐EGFP, to directly assess AAV mediated expression of therapeutic transgenes as intrinsic treatments to improve axonal regeneration. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5436144</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5436144</guid>        </item>
        <item>
            <title>ΔE1 and high‐capacity adenoviral vectors expressing full‐length codon‐optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum</title>
            <link>http://www.medworm.com/index.php?rid=5415606&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1627</link>
            <description>ConclusionsOur findings suggest that Ad vectors expressing full‐length codon‐optimized MSP‐1 are promising candidate vaccines against Plasmodium falciparum infections. Use of the HC‐Ad vector type for delivery and the CAG promoter to control MSP‐1 expression may further increase efficacy of this vaccine candidate. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415606</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415606</guid>        </item>
        <item>
            <title>High‐capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 Ad vectors to induce multispecific transgene product‐directed CD8 T cell responses</title>
            <link>http://www.medworm.com/index.php?rid=5415605&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1629</link>
            <description>ConclusionsDe novo expression of viral genes from ΔE1Ad vector genomes restricts the multispecificity of transgene product‐specific CTLs by immunodominance effects. HC‐Ad vectors devoid of adenovirus genes are favorable for the induction of both multispecific CD8 T cell responses and high antibody responses. Our results suggest deletion of adenovirus genes as an important means to develop potent adenovirus‐based vectored vaccines. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415605</comments>
            <pubDate>Wed, 16 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415605</guid>        </item>
        <item>
            <title>Targeted expression of herpes simplex virus thymidine kinase in adenovirus‐infected cells reduces virus titers upon treatment with ganciclovir in vitro</title>
            <link>http://www.medworm.com/index.php?rid=5531277&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1638</link>
            <description>ConclusionsWe extended the concept of enzyme/prodrug therapy to adenovirus infections by selectively sensitizing adenovirus‐infected cells to treatment with GCV. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5531277</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5531277</guid>        </item>
        <item>
            <title>Baculovirus‐mediated VEGF‐DΔNΔC Gene Transfer Induces Angiogenesis In Rabbit Skeletal Muscle</title>
            <link>http://www.medworm.com/index.php?rid=5499894&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1637</link>
            <description>ConclusionsWe show the first evidence of biologically significant baculoviral gene transfer in skeletal muscle of NZW rabbits using VEGF‐DΔNΔC as a therapeutic transgene. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5499894</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5499894</guid>        </item>
        <item>
            <title>Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro</title>
            <link>http://www.medworm.com/index.php?rid=5481664&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1635</link>
            <description>ConclusionsCollectively these data demonstrate that cytotoxic rather than cytostatic activity is necessary for efficient vascular disruption in vitro, and bystander killing is not essential. We identify NTR/CB1954 and NTR/metronidazole as candidates for in vivo investigation of vascular targeted gene therapy. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481664</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5481664</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5463703&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1636</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463703</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463703</guid>        </item>
        <item>
            <title>The Journal of Gene Medicine Japanese Society of Gene Therapy Young Investigator Award from 2010</title>
            <link>http://www.medworm.com/index.php?rid=5463702&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1632</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463702</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463702</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5463701&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1631</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463701</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463701</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=5463700&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1630</link>
            <description>No abstract is available for this article. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463700</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463700</guid>        </item>
        <item>
            <title>Efficient transgene expression from naked DNA delivered into an arterio‐venous fistula model for kidney dialysis</title>
            <link>http://www.medworm.com/index.php?rid=5329103&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1615</link>
            <description>ConclusionsThese findings open the possibility of vascular transduction with naked DNA bearing therapeutic genes in areas prone to NIH to ameliorate vein graft pathologies using simple and clinically applicable vector delivery methods. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5329103</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5329103</guid>        </item>
        <item>
            <title>Chemical coupling as a potent strategy for preparation of targeted bacteriophage‐derived gene nanocarriers into eukaryotic cells</title>
            <link>http://www.medworm.com/index.php?rid=5329102&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1617</link>
            <description>ConclusionsOur findings highlight chemical coupling as an efficient and straightforward strategy for displaying of a targeting molecule at high density on the phage surface which, in its turn, may improve the efficiency of phage‐mediated gene transfer and expression. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5329102</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5329102</guid>        </item>
        <item>
            <title>Multiple components in serum contribute to hepatic transgene expression by lipoplex in mice</title>
            <link>http://www.medworm.com/index.php?rid=5329101&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1618</link>
            <description>ConclusionsHepatic transgene expression by lipoplex was enhanced by interaction with multiple components in serum. Interaction of lipoplex with serum could be an important factor for successful in vivo gene transfer. Hence, the information obtained in this study is valuable for the future development of effective gene carriers. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5329101</comments>
            <pubDate>Mon, 17 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5329101</guid>        </item>
        <item>
            <title>A syringe Focused Ultrasound Device for Simultaneous Injection of DNA and Gene Transfer</title>
            <link>http://www.medworm.com/index.php?rid=5446414&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1633</link>
            <description>ConclusionsThe new technique provides a simple, safe and efficient nonviral gene delivery approach in skeletal muscle and shows promising applications for gene therapy of human disease, such as Alzheimer's Disease (AD). Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5446414</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5446414</guid>        </item>
        <item>
            <title>Corneal gene delivery: chitosan oligomer as a carrier of CpG rich, CpG free, or S/MAR plasmid DNA</title>
            <link>http://www.medworm.com/index.php?rid=5436143&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1634</link>
            <description>ConclusionsThis study reveals the potential of comparing various plasmids as an approach to enhance transgene expression. The delivery system designed here represents the next step in the development of effective vectors for corneal gene therapy. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5436143</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5436143</guid>        </item>
        <item>
            <title>RGD peptide‐modified adenovirus expressing HGF and XIAP improves islet transplantation</title>
            <link>http://www.medworm.com/index.php?rid=5415604&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1626</link>
            <description>ConclusionThese results indicated that ex vivo transduction of islets with RGD‐Adv‐hHGF‐hXIAP decreased apoptotic islet cell death, improved islet revascularization, and eventually might improve the outcome of human islet transplantation. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415604</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415604</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5353714&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1623</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353714</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353714</guid>        </item>
        <item>
            <title>Gene delivery to the heart: an updated review on vectors and methods</title>
            <link>http://www.medworm.com/index.php?rid=5353713&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1619</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353713</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353713</guid>        </item>
        <item>
            <title>Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model</title>
            <link>http://www.medworm.com/index.php?rid=5353712&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1603</link>
            <description>ConclusionsThese results demonstrate that transfer of the genomic‐cDNA hybrid expressing both isoforms of the HGF gene might provide higher therapeutic effects than the cDNA sequence producing HGF728 alone in the treatment of ischemic heart disease. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353712</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353712</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5353711&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1622</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353711</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353711</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=5353710&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1621</link>
            <description>No abstract is available for this article. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353710</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353710</guid>        </item>
        <item>
            <title>Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5353709&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1624</link>
            <description>ConclusionThis study emphasizes the importance of the route of administration of the vector and highlights the relevance of systemic injection of oncolytic vaccinia virus in the context of hepatocellular carcinoma. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353709</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353709</guid>        </item>
        <item>
            <title>Thermosensitive Hydrogel for Prolonged Delivery of Lentiviral Vector Expressing Neurotrophin‐3 in vitro</title>
            <link>http://www.medworm.com/index.php?rid=5266879&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1613</link>
            <description>ConclusionsThe system shows promise for in‐situ, thermoresponsive delivery of lentiviral vectors providing long term gene expression for therapeutic factors to treat conditions such as injury to the nervous system. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266879</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266879</guid>        </item>
        <item>
            <title>Model‐specific selection of molecular targets for heart failure gene therapy</title>
            <link>http://www.medworm.com/index.php?rid=5256157&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1610</link>
            <description>SummaryHeart failure (HF) is a complex multifaceted problem of abnormal ventricular function and structure. In recent years we have accumulated new information allowing for a more detailed understanding of the cellular and molecular alterations that are the underpinnings of diverse causes of HF including myocardial ischemia, pressure‐overload, volume‐overload or intrinsic cardiomyopathy. Modern pharmacological approaches to treat of HF have had a significant impact on the course of the disease, but they do not reverse the underlying pathological state of the heart. Therefore gene‐based therapy holds a great potential as a targeted treatment for cardiovascular diseases. Here we survey the relative therapeutic efficacy of genetic modulation of β‐adrenergic receptor signaling, Ca2+ h...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256157</comments>
            <pubDate>Fri, 23 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5256157</guid>        </item>
        <item>
            <title>Evidence of DNA Transfer across a Model Membrane by a Neutral Amphiphilic Block Copolymer</title>
            <link>http://www.medworm.com/index.php?rid=5256156&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1612</link>
            <description>ConclusionThese results strongly suggest that gene transfection by neutral block copolymers may involve the formation of cellular pores; in addition, they also highlight that in vivo gene transfection requires the use of adequately soluble block copolymers. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256156</comments>
            <pubDate>Fri, 23 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5256156</guid>        </item>
        <item>
            <title>Gene delivery methods in cardiac gene therapy</title>
            <link>http://www.medworm.com/index.php?rid=5256155&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1609</link>
            <description>AbstractGene therapy for the treatment of heart failure is emerging as a multidisciplinary field with advancements in identifying key signaling pathways, modernized vector creation and delivery technologies. While these discoveries offer significant progress, selecting optimal methods for the vector delivery remains a key component for efficient cardiac gene therapy to validate the targets in rodent models and to test clinically relevant ones in pre‐clinical models. While the goals of higher transduction efficiency and cardiac specificity can be achieved with several delivery methods, the invasiveness and patient safety remain unclear for clinical application. In this review, we discuss various features of currently available vector delivery methods for cardiac gene therapy. Copyright ©...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256155</comments>
            <pubDate>Fri, 23 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5256155</guid>        </item>
        <item>
            <title>A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia</title>
            <link>http://www.medworm.com/index.php?rid=5342119&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1614</link>
            <description>ConclusionThese results support the performance of a phase II randomized controlled trial with pCK‐HGF‐X7. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5342119</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5342119</guid>        </item>
        <item>
            <title>Targeted expression of E. coli purine nucleoside phosphorylase and Fludara for prostate cancer therapy</title>
            <link>http://www.medworm.com/index.php?rid=5329100&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1620</link>
            <description>ConclusionsThe ARR2PB‐PNP/Fludara system induced massive tumor cell death and prolonged life span without systemic cytotoxicity, therefore it might be a more attractive strategy for suicide gene therapy of prostate cancer. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5329100</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5329100</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5266885&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1607</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266885</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266885</guid>        </item>
        <item>
            <title>Long‐term functional adeno‐associated virus‐microdystrophin expression in the dystrophic CXMDj dog</title>
            <link>http://www.medworm.com/index.php?rid=5266884&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1602</link>
            <description>ConclusionsThe data obtained in the present study suggest that the use of canine‐specific and mRNA sequence‐optimized microdystrophin genes in conjunction with a muscle‐specific promoter results in high and stable levels of microdystrophin expression in a canine model of DMD. This approach will potentially allow the reduction of dosage and contribute towards the development of a safe and effective AAV gene therapy clinical trial protocol for DMD. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266884</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266884</guid>        </item>
        <item>
            <title>Non‐integrating lentiviral vectors for specific killing of Epstein–Barr virus nuclear antigen 1‐positive B cell lymphoma cells</title>
            <link>http://www.medworm.com/index.php?rid=5266883&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1601</link>
            <description>ConclusionsTransgene expression from our NILVs is both EBNA1‐specific and dependent upon the presence of the FR. The results obtained in the present study indicate that NILVs have potential use in the treatment of EBV‐associated B cell malignancies. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266883</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266883</guid>        </item>
        <item>
            <title>The position of the AUG start codon in MFG‐based γ‐retroviral vectors has a dramatic effect on translation‐dependent protein expression</title>
            <link>http://www.medworm.com/index.php?rid=5266882&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1599</link>
            <description>ConclusionsThese finding emphasize the scanning rule for translation initiation and stress the importance of cloning genes of interest into or near the native NcoI start site of MFG‐based retroviral vectors. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266882</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266882</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5266881&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1606</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266881</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266881</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=5266880&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1605</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266880</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266880</guid>        </item>
        <item>
            <title>Effect of VEGF gene transfer on infarct size, left ventricular function and myocardial perfusion in sheep after two months of coronary artery occlusion</title>
            <link>http://www.medworm.com/index.php?rid=5266878&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1608</link>
            <description>ConclusionsIn sheep with AMI pVEGF gene transfer affords long term infarct size reduction, yielding regional LV function and perfusion improvement and reducing remodeling progression. These results suggest the potential usefulness of this approach in the clinical setting. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266878</comments>
            <pubDate>Thu, 01 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266878</guid>        </item>
        <item>
            <title>Non‐integrating lentiviral vectors for specific killing of Epstein‐Barr virus nuclear antigen 1‐positive B cell lymphoma cells</title>
            <link>http://www.medworm.com/index.php?rid=5153420&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1601</link>
            <description>ConclusionTransgene expression from our NILVs is both EBNA1‐specific and dependent upon the presence of the FR. Results from this study indicate that NILVs have potential use in the treatment of EBV‐associated B cell malignancies. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153420</comments>
            <pubDate>Tue, 16 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153420</guid>        </item>
        <item>
            <title>Intracellular trafficking and fate of chimeric adenovirus 5/F35 in human B lymphocytes</title>
            <link>http://www.medworm.com/index.php?rid=5034569&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1588</link>
            <description>ConclusionsTogether, these results suggest that Ad5/F35 is more efficiently transduced in cells with a strong transcriptional activity due to differences in intracellular trafficking. This finding extends our current knowledge of mechanisms of adenovirus‐mediated gene transfer. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5034569</comments>
            <pubDate>Thu, 14 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5034569</guid>        </item>
        <item>
            <title>Endonucleases: tools to correct the dystrophin gene</title>
            <link>http://www.medworm.com/index.php?rid=5256154&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1611</link>
            <description>ConclusionsEndonucleases are able to: 1) restore the normal reading of a gene with a frame shift mutation; 2) delete a non‐sense codon and 3) knockout a gene. Endonucleases could thus be used to treat Duchenne Muscular Dystrophy (DMD) and other hereditary diseases due to a nonsense codon or to a frame shift mutation. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256154</comments>
            <pubDate>Fri, 01 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5256154</guid>        </item>
        <item>
            <title>Lentiviral‐based BMP4 in vivo gene transfer strategy increases pull‐out tensile strength without an improvement in the osteointegration of the tendon graft in a rat model of biceps tenodesis</title>
            <link>http://www.medworm.com/index.php?rid=5189776&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1604</link>
            <description>ConclusionAlthough the LV‐BMP4 in vivo gene transfer strategy did not enhance osteointegration of the tendon graft, it yielded a marked improvement in the return of the pull‐out strength of the tendon graft. This presumably was due largely to the bone formation effect of BMP4 that traps or anchors the tendon graft onto the bony tunnel. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5189776</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5189776</guid>        </item>
        <item>
            <title>Enhanced cardio‐protective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model</title>
            <link>http://www.medworm.com/index.php?rid=5167584&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1603</link>
            <description>ConclusionsThese results demonstrated that transfer of the genomic‐cDNA hybrid expressing both isoforms of the HGF gene might provide higher therapeutic effects than the cDNA sequence producing HGF728 alone in the treatment of ischemic heart diseases. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5167584</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5167584</guid>        </item>
        <item>
            <title>Long‐term functional AAV‐microdystrophin expression in the dystrophic CXMDj dog</title>
            <link>http://www.medworm.com/index.php?rid=5153419&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1602</link>
            <description>ConclusionsOur data suggests that use of a canine‐specific and mRNA sequence‐optimized microdystrophin genes in conjunction with a muscle‐specific promoter results in high and stable levels of microdystrophin expression in a canine model of DMD. This approach will potentially allow reduction of dosage and contribute towards development of a safe and effective AAV gene therapy clinical trial protocol for DMD. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153419</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153419</guid>        </item>
        <item>
            <title>The Evolution of Heart Gene Delivery Vectors</title>
            <link>http://www.medworm.com/index.php?rid=5115598&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1600</link>
            <description>AbstractGene therapy holds promise for treating numerous heart diseases. A key premise for the success of cardiac gene therapy is the development of powerful gene transfer vehicles that can achieve highly efficient and persistent gene transfer specifically in the heart. Other features of an ideal vector include negligible toxicity, minimal immunogenicity and easy manufacturing. Rapid progress in the fields of molecular biology and virology has offer great opportunities to engineer various genetic materials for heart gene delivery. Several non‐viral vectors (such as naked plasmids, plasmid lipid/polymer complexes and oligonucleotides) have been tested. Commonly used viral vectors include lentivirus, adenovirus and adeno‐associated virus (AAV). Among these, AAV has shown many attractive ...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115598</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5115598</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5075066&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1592</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5075066</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5075066</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5075065&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1591</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5075065</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5075065</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=5075064&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1593</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5075064</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5075064</guid>        </item>
        <item>
            <title>The position of the AUG start codon in MFG‐based γ‐retroviral vectors has a dramatic effect on translation dependent protein expression</title>
            <link>http://www.medworm.com/index.php?rid=5075063&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1599</link>
            <description>ConclusionsThese finding emphasize the scanning rule for translation initiation and stress the importance of cloning genes of interest into or near the native Nco I start site of MFG‐based retroviral vectors. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5075063</comments>
            <pubDate>Thu, 30 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5075063</guid>        </item>
        <item>
            <title>Mechanisms of polyethylenimine‐mediated DNA delivery: free carrier helps to overcome the barrier of cell‐surface glycosaminoglycans</title>
            <link>http://www.medworm.com/index.php?rid=4990378&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1587</link>
            <description>ConclusionsFree PEI is essential for minimizing the undesirable binding of polyplexes to cell‐surface GAGs that have negative impact on transfection. The same mechanism may be important in transfections with other polyplexes that require high charge ratios for transfection. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4990378</comments>
            <pubDate>Wed, 29 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4990378</guid>        </item>
        <item>
            <title>Therapeutic ultrasound promotes plasmid DNA uptake by clathrin‐mediated endocytosis</title>
            <link>http://www.medworm.com/index.php?rid=4990377&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1586</link>
            <description>ConclusionsThe present data indicate that the plasmid DNA uptake promoted by US should occur via clathrin‐mediated endocytosis. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4990377</comments>
            <pubDate>Wed, 29 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4990377</guid>        </item>
        <item>
            <title>7th Australasian Gene Therapy Society meeting</title>
            <link>http://www.medworm.com/index.php?rid=4973915&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1582</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973915</comments>
            <pubDate>Sun, 26 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973915</guid>        </item>
        <item>
            <title>Gene therapy with adenovirus‐delivered indoleamine 2,3‐dioxygenase improves renal function and morphology following allogeneic kidney transplantation in rat</title>
            <link>http://www.medworm.com/index.php?rid=4973914&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1584</link>
            <description>ConclusionsRGD‐AdTIDO therapy improves renal function and morphology in a clinically relevant model of acute rejection. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973914</comments>
            <pubDate>Sun, 26 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973914</guid>        </item>
        <item>
            <title>Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in mouse squamous cell carcinoma model</title>
            <link>http://www.medworm.com/index.php?rid=4930495&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1578</link>
            <description>ConclusionThese findings suggest that CBOVS could protect adenoviruses from neutralizing antibodies and systemically deliver them to lung tumors. Further, CBOVS appears to have potential as a tumor cell vaccine that activates cytotoxic immunity against cancer cells. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930495</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930495</guid>        </item>
        <item>
            <title>Effect of poly(ADP‐ribose) polymerase 1 on integration of the adeno‐associated viral vector genome</title>
            <link>http://www.medworm.com/index.php?rid=4930494&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1577</link>
            <description>ConclusionsOur findings indicate that manipulation of PARP1 activity could be used as a tool for developing new, effective AAV‐based therapies for the treatment of genetic diseases and cancer. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930494</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930494</guid>        </item>
        <item>
            <title>A Single Direct Injection into the Left Ventricular Wall of an AAV9 Vector Expressing EcSOD from the Cardiac Troponin‐T Promoter Protects Mice Against Myocardial Infarction</title>
            <link>http://www.medworm.com/index.php?rid=4930493&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1576</link>
            <description>ConclusionsAAV serotype 9 is highly efficient for cardiac gene delivery, as evidenced by early onset and high‐level gene expression. AAV9 mediated, cardiac selective overexpression of EcSOD from the cTnT promoter significantly reduced infarct size in mice.AAV, gene therapy, cardiac‐selective promoter, myocardial infarction, cardioprotection, EcSOD Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930493</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930493</guid>        </item>
        <item>
            <title>AAV‐Mediated Expression of Acid Sphingomyelinase Decreases Atherosclerotic Lesion Formation in Apolipoprotein E−/− Mice</title>
            <link>http://www.medworm.com/index.php?rid=4930492&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1575</link>
            <description>ConclusionsUnexpectedly, the lesion area of the entire aorta was actually reduced significantly in the AAV8‐ASM virus‐treated group. Hepatic expression and secretion of ASM into the circulation did not accelerate or exacerbate, but rather decreased lesion formation in ApoE−/− mice. Thus, plasma ASM activity does not appear to be rate limiting for plaque formation during atherogenesis. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930492</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930492</guid>        </item>
        <item>
            <title>Enhanced delivery of mPEG‐PLGA‐PLL nanoparticles loading PDGF‐BB siRNA by ultrasound and/or microbubbles to rat RPE cells</title>
            <link>http://www.medworm.com/index.php?rid=4930491&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1574</link>
            <description>ConclusionsUS and/or MBs could be used safely to enhance the delivery of NPs loading siRNA to rat RPE‐J cells. A combination of the chemical (mPEG‐PLGA‐PLL NPs loading siRNA) and physical (ultrasound) approaches could more effectively downregulate the mRNA and protein expression of PDGF‐BB. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930491</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930491</guid>        </item>
        <item>
            <title>Immunity against a therapeutic xenoprotein/Fc construct delivered by gene transfer is reduced through binding to the inhibitory receptor FcγRIIb</title>
            <link>http://www.medworm.com/index.php?rid=5056605&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1598</link>
            <description>ConclusionsThis study shows that inhibitory FcγRIIb receptors interacting with the wild‐type IgG1‐Fc reduce immunity against Ex4/Fc, and suggest an approach for reducing the immunogenicity of therapeutic proteins in the context of gene therapy. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5056605</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5056605</guid>        </item>
        <item>
            <title>Sleeping Beauty‐mediated correction of Fanconi anemia type C</title>
            <link>http://www.medworm.com/index.php?rid=5034568&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1589</link>
            <description>ConclusionsThe SB transposon system achieved stable expression of therapeutic FA‐C genes, complementing the genetic defect in patient‐derived cells by non‐viral gene transfer. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5034568</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5034568</guid>        </item>
        <item>
            <title>Sustained, high transgene expression in liver with plasmid vectors using optimized promoter‐enhancer combinations</title>
            <link>http://www.medworm.com/index.php?rid=4990376&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1585</link>
            <description>AbstractPlasmid based gene therapy approaches often lack long term transgene expression in vivo due to silencing or loss of the vector. One way to overcome these limitations is to combine non‐silenced promoters with strong enhancers. Here we combine murine or human cytomegalovirus (CMV) derived enhancer elements with the human elongation factor 1 alpha (EF1α) promoter in a plasmid backbone devoid of potentially immunostimulating CpG sequences. Luciferase transgene activity was monitored in mouse liver after hydrodynamic plasmid delivery. Luciferase activity of a CMV promoter driven plasmid rapidly declined within days, whereas the activity of the EF1α driven plasmid remained high for two weeks (murine enhancer) and detectable for &amp;gt;80 days (human enhancer). Expression levels clearl...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4990376</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4990376</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4973923&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1581</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973923</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973923</guid>        </item>
        <item>
            <title>Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in a mouse squamous cell carcinoma model</title>
            <link>http://www.medworm.com/index.php?rid=4973922&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1578</link>
            <description>ConclusionsThese findings suggest that CBOVS could protect adenoviruses from neutralizing antibodies and systemically deliver them to lung tumors. Furthermore, CBOVS appears to have potential as a tumor cell vaccine that activates cytotoxic immunity against cancer cells. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973922</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973922</guid>        </item>
        <item>
            <title>A single direct injection into the left ventricular wall of an adeno‐associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin‐T promoter protects mice against myocardial infarction</title>
            <link>http://www.medworm.com/index.php?rid=4973921&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1576</link>
            <description>ConclusionsAAV serotype 9 is highly efficient for cardiac gene delivery, as evidenced by early onset and high‐level gene expression. AAV9‐mediated, cardiac selective overexpression of EcSOD from the cTnT promoter significantly reduced infarct size in mice. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973921</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973921</guid>        </item>
        <item>
            <title>Adeno‐associated virus‐mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E−/− mice</title>
            <link>http://www.medworm.com/index.php?rid=4973920&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1575</link>
            <description>ConclusionsUnexpectedly, the lesion area of the entire aorta was reduced significantly in the AAV8‐ASM virus‐treated group. Hepatic expression and secretion of ASM into the circulation did not accelerate or exacerbate, but rather decreased, lesion formation in ApoE−/− mice. Thus, plasma ASM activity does not appear to be rate limiting for plaque formation during atherogenesis. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973920</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973920</guid>        </item>
        <item>
            <title>Enhanced delivery of monomethoxypoly(ethylene glycol)‐poly(lactic‐co‐glycolic acid)‐poly l‐lysine nanoparticles loading platelet‐derived growth factor BB small interfering RNA by ultrasound and/or microbubbles to rat retinal pigment epithelium cells</title>
            <link>http://www.medworm.com/index.php?rid=4973919&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1574</link>
            <description>ConclusionsUS and/or MBs could be used safely to enhance the delivery of NPs loading siRNA to rat RPE‐J cells. A combination of the chemical (mPEG‐PLGA‐PLL NPs loading siRNA) and physical (US) approaches could more effectively downregulate the mRNA and protein expression of PDGF‐BB. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973919</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973919</guid>        </item>
        <item>
            <title>The multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster as a therapeutic suicide gene of breast cancer cells</title>
            <link>http://www.medworm.com/index.php?rid=4973918&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1573</link>
            <description>ConclusionsThese results suggest that the Dm‐dNK/nucleoside analog system could be a novel therapeutic strategy for treating breast cancer and improving anti‐tumor efficacy, as well as for optimizing approaches for suicide gene therapy. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973918</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973918</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=4973917&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1580</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973917</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973917</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=4973916&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1579</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973916</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973916</guid>        </item>
        <item>
            <title>Hepatic Control Elements Promote Long‐term Expression of Human Coagulation Factor IX Gene in Hydrodynamically Transfected Mice</title>
            <link>http://www.medworm.com/index.php?rid=4973913&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1583</link>
            <description>ConclusionsWe have shown in mouse models that hydrodynamic transfection of pBS‐HCRII‐HP‐FIXA and pBS‐HCRI/II‐HP‐FIXA was able to induce and maintain the expression and clotting activity of human factor IX for a long period of time at a potentially therapeutic level. With an appropriate delivery system this type of plasmid vector could be clinically useful for hepatic expression of therapeutic genes including human factor IX. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973913</comments>
            <pubDate>Tue, 31 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4973913</guid>        </item>
        <item>
            <title>The multisubstrate deoxyribonucleoside kinase of D. melanogaster as a therapeutic suicide gene of breast cancer cells</title>
            <link>http://www.medworm.com/index.php?rid=4930490&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1573</link>
            <description>ConclusionsThese results suggest that the Dm‐dNK/nucleoside analog system could be a novel therapeutic strategy to treat breast cancer and improve anti‐tumor efficacy, as well as optimize approaches for suicide gene therapy. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930490</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930490</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4909387&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1572</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909387</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4909387</guid>        </item>
        <item>
            <title>Development of a successive targeting liposome with multi‐ligand for efficient targeting gene delivery</title>
            <link>http://www.medworm.com/index.php?rid=4909386&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1569</link>
            <description>ConclusionsSTL with multi‐ligand was able to overcome the various barriers to target nucleus and special cells and present distinctive transgenic expression. Therefore, it has a great potential for gene therapy as a nonviral carrier. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909386</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4909386</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=4909385&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1571</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909385</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4909385</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=4909384&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1570</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909384</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4909384</guid>        </item>
        <item>
            <title>Development of a successive targeting liposome (STL) with multi‐ligand for efficient targeting gene delivery</title>
            <link>http://www.medworm.com/index.php?rid=4826977&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1569</link>
            <description>ConclusionsSTL with multi‐ligand was able to overcome the various barriers to target nucleus and special cells and present distinctive transgenic expression. Therefore it has a great potential for gene therapy as a non‐viral carrier. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4826977</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4826977</guid>        </item>
        <item>
            <title>Adeno‐associated virus‐mediated human acidic fibroblast growth factor expression promotes functional recovery of spinal cord–contused rats</title>
            <link>http://www.medworm.com/index.php?rid=4797314&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1568</link>
            <description>ConclusionsThese data suggest that supplement of aFGF improve the functional recovery of spinal cord–contused rats and that AAV‐aFGF‐mediated gene transfer could be a clinically feasible therapeutic approach for patients after nervous system injuries. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4797314</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4797314</guid>        </item>
        <item>
            <title>An Evaluation of Site‐Specific Immune Responses Directed Against First‐Generation Adenoviral Vectors Administered by Convection‐Enhanced Delivery</title>
            <link>http://www.medworm.com/index.php?rid=4787149&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1567</link>
            <description>ConclusionThese results indicate that CED is capable of mediating widespread adenoviral vector distribution, although these vectors are associated with significant tissue toxicity that may render their safe application in clinical trials unfeasible. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4787149</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4787149</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4752125&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1564</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752125</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752125</guid>        </item>
        <item>
            <title>Evaluation of nonbiomedical and biomedical grade alginates for the transplantation of genetically modified articular chondrocytes to cartilage defects in a large animal model in vivo</title>
            <link>http://www.medworm.com/index.php?rid=4752124&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1557</link>
            <description>ConclusionsThis approach may be of value to study the effects of potential therapeutic genes upon cartilage repair in a clinically relevant setting. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752124</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752124</guid>        </item>
        <item>
            <title>Attenuated Actinobacillus pleuropneumoniae as a bacterial vector for expression of Mycoplasma hyopneumoniae P36 gene</title>
            <link>http://www.medworm.com/index.php?rid=4752123&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1556</link>
            <description>ConclusionsThe mutant strain SLW36 can induce antibody against p36 and M. hyopneumoniae. The mutant strain SLW36 has the potential to be used as a live vaccine for protection against A. pleuropneumoniae and M. hyopneumoniae. Studies in pigs are needed to confirm protective levels of antibodies and to check for rare side‐effects of the vaccine. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752123</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752123</guid>        </item>
        <item>
            <title>Sustained inhibition of IL‐6 and IL‐8 expression by decoy ODN to NF‐κB delivered through respirable large porous particles in LPS‐stimulated cystic fibrosis bronchial cells</title>
            <link>http://www.medworm.com/index.php?rid=4752122&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1546</link>
            <description>ConclusionsOur observations indicate that respirable biodegradable dec‐ODN LPP may represent a promising strategy for inhibiting NF‐κB transcriptional activity and related gene expression and, thus, reduce lung chronic inflammation in CF patients. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752122</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752122</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=4752121&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1562</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752121</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752121</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=4752120&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1560</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752120</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752120</guid>        </item>
        <item>
            <title>Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease</title>
            <link>http://www.medworm.com/index.php?rid=4752119&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1566</link>
            <description>Conclusions:In FD mice, reconstitution with 100% donor cells is not required to obtain a therapeutic effect following bone marrow transplantation. These results suggest that a 30% gene correction might be sufficient to reverse the disease manifestations in FD. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752119</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4752119</guid>        </item>
        <item>
            <title>Inhibition of highly pathogenic avian H5N1 influenza virus propagation by RNA oligonucleotides targeting the PB2 gene in combination with celecoxib</title>
            <link>http://www.medworm.com/index.php?rid=4657320&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1558</link>
            <description>In this study, we attempted to explore if the combinational use of a viral gene‐targeted agent and immunomodulator is feasible as a new strategy against the H5N1 infection. Four antisense RNA oligonucleotides targeting the polymerase basic protein 2 (PB2) gene of H5N1‐HPIV were designed and screened for their ability to inhibit H5N1 influenza viral propagation. In MDCK cells, the RNA oligonucleotides efficiently inhibited viral replication, as measured by hemagglutinin production, plaque formation and viral RNA expression assays. In a mouse infection model, a combinational treatment in mice with the PB2 oligonucleotides and celecoxib significantly reduced the viral load, regulated cytokine profiles, and improved lung lesions and animal survival in comparison with the single use of eith...</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4657320</comments>
            <pubDate>Tue, 29 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4657320</guid>        </item>
        <item>
            <title>Knock down of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease</title>
            <link>http://www.medworm.com/index.php?rid=4657322&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1555</link>
            <description>ConclusionsWe conclude that RNAi directed against GAD67 may be a valid approach to correct the dysregulation of the basal ganglia circuit in a rat model of Parkinson's disease. The possibility to correct for a loss of dopamine using non‐dopamimetic tools is interesting as it may be more directed towards the casual mechanisms of the motor symptoms. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4657322</comments>
            <pubDate>Mon, 28 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4657322</guid>        </item>
        <item>
            <title>Evaluation of non‐biomedical and biomedical grade alginates for the transplantation of genetically modified articular chondrocytes to cartilage defects in a large animal model in vivo</title>
            <link>http://www.medworm.com/index.php?rid=4657321&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1557</link>
            <description>ConclusionsThis approach may be of value to study the effects of potential therapeutic genes upon cartilage repair in a clinically relevant setting. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4657321</comments>
            <pubDate>Mon, 28 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4657321</guid>        </item>
        <item>
            <title>Endostatin‐ and interleukin‐2‐expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4511019&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1547</link>
            <description>ConclusionRetroviral bicistronic gene transfer led to the secretion of functional ES and IL‐2 that were sufficiently active to inhibit tumor angiogenesis and tumor cell proliferation and to increase the infiltration of immune cells. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4511019</comments>
            <pubDate>Tue, 22 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4511019</guid>        </item>
        <item>
            <title>Intracellular efficacy of tumor‐targeting group I intron‐based trans‐splicing ribozyme</title>
            <link>http://www.medworm.com/index.php?rid=4476339&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1545</link>
            <description>Conclusion:We analyzed ribozyme efficacy and determined the most influential factors of its trans‐splicing reaction in mammalian cell lines and in vivo. This study could provide insights into the optimization of the trans‐splicing ribozyme‐based RNA replacement approach to cancer treatment. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4476339</comments>
            <pubDate>Tue, 15 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4476339</guid>        </item>
        <item>
            <title>Stem cell antigen‐1 positive cell–based systemic human growth hormone gene transfer strategy increased endosteal bone resorption and bone loss in mice</title>
            <link>http://www.medworm.com/index.php?rid=4476342&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1542</link>
            <description>ConclusionTargeted expression of hGH in cells of marrow cavity through the Sca‐1+ cell‐based gene transfer strategy increased circulating IGF‐I and decreased endosteal bone mass through an increase in resorption in recipient mice. These results indicate that high local levels of hGH or IGF‐I in the bone marrow microenvironment enhanced resorption, which are consistent with previous findings in transgenic mice with targeted bone IGF‐I expression that high local IGF‐I expression increased bone remodeling that favored a net bone loss. Thus, the GH and/or IGF‐I would not be an appropriate transgene for use in this Sca‐1+ cell‐based gene transfer strategy to promote endosteal bone formation. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4476342</comments>
            <pubDate>Mon, 14 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4476342</guid>        </item>
        <item>
            <title>Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self‐complementary adeno‐associated virus vector</title>
            <link>http://www.medworm.com/index.php?rid=4476341&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1543</link>
            <description>ConclusionComplete phenotypic correction of PKU mice was achieved by the scAAV8 vector for the longest duration reported to date. The vector overcame the female‐specific disadvantage in AAV‐mediated liver transduction, thus it offers a promising platform of long‐lasting gene therapy for PKU. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4476341</comments>
            <pubDate>Mon, 14 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4476341</guid>        </item>
        <item>
            <title>Infant lungs are preferentially infected by adenovirus and herpes simplex virus type 1 vectors: role of the tissue mesenchymal cells</title>
            <link>http://www.medworm.com/index.php?rid=4476340&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1544</link>
            <description>Conclusion:the similarity of the human and mouse tissues, with respect to viral vector tropism, validates the mouse model in studies of gene transfer to the lung. Furthermore, the results should facilitate improved design of gene therapy trials for lung related diseases in young and adults patients. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4476340</comments>
            <pubDate>Mon, 14 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4476340</guid>        </item>
        <item>
            <title>Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=4746947&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1565</link>
            <description>Conclusions:Our results extend previous preclinical reports into human cancer patients and suggest that modification of fiber knob is a feasible strategy to circumvent NAb response in patients receiving multiple rounds of oncolytic adenoviruses. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4746947</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4746947</guid>        </item>
        <item>
            <title>Mesenchymal stem cells as vehicles for targeted delivery of antiangiogenic protein to solid tumors</title>
            <link>http://www.medworm.com/index.php?rid=4657319&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1552</link>
            <description>ConclusionhMSC may serve as an effective platform for the targeted delivery of therapeutic proteins to cancer sites. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4657319</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4657319</guid>        </item>
        <item>
            <title>Attenuated Actinobcillus pleuropneumoniae as a bacterial vector for expression of Mycoplasma hyopneumoniae P36 gene</title>
            <link>http://www.medworm.com/index.php?rid=4625684&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1556</link>
            <description>ConclusionThe mutant strain SLW36 can induce antibody against p36 and M. hyopneumoniae. The mutant strain SLW36 has the potential to be used as a live vaccine for protection against A. pleuropneumoniae and M. hyopneumoniae. Studies in pigs are needed to confirm protective levels of antibodies and to check for rare side effects of the vaccine. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4625684</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4625684</guid>        </item>
        <item>
            <title>Characterization of factors that determine lentiviral vector tropism in skin tissue using an ex vivo model</title>
            <link>http://www.medworm.com/index.php?rid=4609580&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1554</link>
            <description>ConclusionsTaken together the results indicated that lentiviral vector tropism in the three dimensional skin tissue is distinct of the tropism to keratinocytes in culture and is dependent on a complex interplay of extracellular restrictions. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4609580</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4609580</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4589146&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1551</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4589146</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4589146</guid>        </item>
        <item>
            <title>Visualization of intracellular trafficking of Math1 protein in different cell types with a newly‐constructed nonviral gene delivery plasmid</title>
            <link>http://www.medworm.com/index.php?rid=4589145&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1537</link>
            <description>ConclusionsThe newly‐constructed plasmid pcDNA6.2/C‐EmGFP‐Math1 was suitable for nonviral gene delivery of Math1. Unique intracellular trafficking of Math1 with dynamics from the cytoplasm to the nucleus was demonstrated. The modification of mesenchymal stem cells by Math1 gene delivery and by brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor treatments can potentially be applied to cell replacement for the treatment of cochlear spiral ganglion cell loss in deafness. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4589145</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4589145</guid>        </item>
        <item>
            <title>Stem cell antigen‐1 positive cell‐based systemic human growth hormone gene transfer strategy increases endosteal bone resorption and bone loss in mice</title>
            <link>http://www.medworm.com/index.php?rid=4589144&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1542</link>
            <description>ConclusionsTargeted expression of hGH in cells of marrow cavity through the Sca‐1+ cell‐based gene transfer strategy increased circulating IGF‐I and decreased endosteal bone mass through an increase in resorption in recipient mice. These results indicate that high local levels of hGH or IGF‐I in the bone marrow microenvironment enhanced resorption, which is consistent with previous findings in transgenic mice with targeted bone IGF‐I expression showing that high local IGF‐I expression increased bone remodeling, favoring a net bone loss. Thus, GH and/or IGF‐I would not be an appropriate transgene for use in this Sca‐1+ cell‐based gene transfer strategy to promote endosteal bone formation. Published 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4589144</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4589144</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=4589143&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1550</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4589143</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4589143</guid>        </item>
        <item>
            <title>Issue Information</title>
            <link>http://www.medworm.com/index.php?rid=4589142&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1549</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4589142</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4589142</guid>        </item>
        <item>
            <title>A lentiviral vector pseudotype suitable for vaccine development</title>
            <link>http://www.medworm.com/index.php?rid=4569420&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1553</link>
            <description>ConclusionRRV envelope is a suitable candidate to be used for construction of an LV producer cell line. LV vaccines with RRV envelope can be tested in mice and in human immune cell cultures. The higher dose of RRV‐LV required for vaccine efficacy compared to VSV‐G‐LV will partly be offset by ease of production. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4569420</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4569420</guid>        </item>
        <item>
            <title>Nuclear targeted delivery of macromolecules to retina and cornea</title>
            <link>http://www.medworm.com/index.php?rid=4511018&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1548</link>
            <description>ConclusionsOur results demonstrate that NBP can deliver small and large molecules into retinal and corneal cells and plasmid DNA into retinal cells and hence may be useful for the delivery of therapeutics to the eye. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4511018</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4511018</guid>        </item>
        <item>
            <title>Sustained inhibition of IL‐6 and IL‐8 expression by ODN decoy to NF‐κB delivered through respirable large porous particles in LPS‐stimulated cystic fibrosis bronchial cells</title>
            <link>http://www.medworm.com/index.php?rid=4476338&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1546</link>
            <description>ConclusionsOur observations indicate that respirable biodegradable dec‐ODN LPP may represent a promising strategy to inhibit NF‐κB transcriptional activity and related gene expression and, thus, reduce the lung chronic inflammation in CF patients. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4476338</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4476338</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4398184&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1539</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4398184</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4398184</guid>        </item>
        <item>
            <title>Prophylactic, therapeutic and immune enhancement effect of liposome‐encapsulated PolyICLC on highly pathogenic H5N1 influenza infection</title>
            <link>http://www.medworm.com/index.php?rid=4398183&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1536</link>
            <description>ConclusionsTaken together, the data obtained in the present study suggest that strong consideration should be given for the use of LE‐PolyICLC as prophylactic and therapeutic agents and also as a vaccination adjuvant to combat highly pathogenic influenza infection and its associated complications such as pulmonary fibrosis. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4398183</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4398183</guid>        </item>
        <item>
            <title>Transplantation of CTLA4Ig gene‐transduced adipose tissue‐derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis</title>
            <link>http://www.medworm.com/index.php?rid=4398182&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1531</link>
            <description>ConclusionAlthough CTLA4Ig‐MSC transplantation had better result in reduction of serum TgAA, both of ATMSC and CTLA4Ig‐MSC transplantations are promising treatments for autoimmune thyroiditis judging from the results of histopathology and cytokine analysis. They may be attractive candidates for treating organ‐specific autoimmune disease. Copyright © 2011 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4398182</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4398182</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=4398181&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1541</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4398181</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4398181</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=4398180&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1540</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4398180</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4398180</guid>        </item>
        <item>
            <title>Anti‐DNA antibody modified coronary stent for plasmid gene delivery: results obtained from a porcine coronary stent model</title>
            <link>http://www.medworm.com/index.php?rid=4270702&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1529</link>
            <description>ConclusionsFor the first time, we report the successful use of anti‐DNA antibody‐immobilized stent as plasmid gene delivery system that possess high efficiency and site‐specificity in a porcine coronary stent model. The novel system showed long‐term therapeutic effects on the inhibition of restenosis when pcDNA3.1‐iNOS was tethered on the stent. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4270702</comments>
            <pubDate>Fri, 17 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4270702</guid>        </item>
        <item>
            <title>Creation of a panel of vectors based on ape adenovirus isolates</title>
            <link>http://www.medworm.com/index.php?rid=4270701&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1530</link>
            <description>ConclusionsE1‐deleted adenovirus vectors can be created from a wide variety of ape adenoviruses that can be rescued and propagated in HEK 293 cells. The prevalence of pre‐existing antibodies that can neutralize these adenoviruses in human populations is low. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4270701</comments>
            <pubDate>Fri, 17 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4270701</guid>        </item>
        <item>
            <title>Antiglioma effects of combined use of a baculovirual vector expressing wild‐type p53 and sodium butyrate</title>
            <link>http://www.medworm.com/index.php?rid=4240696&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1522</link>
            <description>ConclusionsThese findings suggest a new approach to treat glioblastoma using baculovirus‐mediated gene transfer in combination with administration of histone deacetylase inhibitor. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4240696</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4240696</guid>        </item>
        <item>
            <title>Improved transfection efficiency of an aliphatic lipid substituted 2 kDa polyethylenimine is attributed to enhanced nuclear association and uptake in rat bone marrow stromal cell</title>
            <link>http://www.medworm.com/index.php?rid=4240695&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1526</link>
            <description>ConclusionsImproved transfection efficiency of PEI2LA was attributed to enhanced association with the nucleus, which may be a result of hydrophobic interaction between the lipid moieties on the modified lipopolymer and the nuclear membrane. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4240695</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4240695</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4257233&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1533</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257233</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257233</guid>        </item>
        <item>
            <title>The 15th Annual Meeting 2009 Japan Society of Gene Therapy</title>
            <link>http://www.medworm.com/index.php?rid=4257232&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1532</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257232</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257232</guid>        </item>
        <item>
            <title>Prevention of intrahepatic metastasis of liver cancer by suicide gene therapy and chemokine ligand 2/monocyte chemoattractant protein‐1 delivery in mice</title>
            <link>http://www.medworm.com/index.php?rid=4257231&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1528</link>
            <description>ConclusionsCollectively, these results demonstrate that an adequate amount of CCL2/MCP‐1, together with the HSV‐tk/GCV system, may induce T helper 1‐polarized antitumor effects without inducing tumor angiogenesis in the microenvironment of intrahepatic HCC progression. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257231</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257231</guid>        </item>
        <item>
            <title>Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia‐inducible gene expression system</title>
            <link>http://www.medworm.com/index.php?rid=4257230&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1527</link>
            <description>ConclusionsWe propose that NSCs engineered with the Epo‐SV‐therapeutic gene will be valuable for developing a controllable stem cell‐mediated nonviral gene therapy for SCI or other central nervous system diseases accompanied with chronic or episodic hypoxic/ischemic stresses. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257230</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257230</guid>        </item>
        <item>
            <title>Electroporation to deliver plasmid DNA into rat dental tissues</title>
            <link>http://www.medworm.com/index.php?rid=4257229&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1521</link>
            <description>ConclusionsThe present study demonstrates for the first time the feasibility of electroporation to locally deliver plasmids into dental tissues. Parameters affecting electroporation to deliver plasmids into the dental tissues were optimized. This protocol could be used to deliver short hairpin RNA or genes of interest into the dental tissues to regulate tooth eruption. Thus, it may be possible to develop nonsurgical treatments for inducing the eruption of impacted teeth. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257229</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257229</guid>        </item>
        <item>
            <title>Publisher's Note</title>
            <link>http://www.medworm.com/index.php?rid=4257228&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1535</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257228</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257228</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=4257227&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1534</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4257227</comments>
            <pubDate>Wed, 01 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4257227</guid>        </item>
        <item>
            <title>Antibody‐directed lentiviral gene transduction in early immature hematopoietic progenitor cells</title>
            <link>http://www.medworm.com/index.php?rid=4195406&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1518</link>
            <description>ConclusionsGene transfer to lineage− early immature hematopoietic progenitors from human umbilical CB was obtained using CD133, ABCG2 or HLA‐1 antibodies conjugated to lentiviruses pseudotyped with modified Sindbis viral Env proteins. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4195406</comments>
            <pubDate>Mon, 22 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4195406</guid>        </item>
        <item>
            <title>Novel tumour‐specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors</title>
            <link>http://www.medworm.com/index.php?rid=4195405&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1519</link>
            <description>ConclusionsWe identified and experimentally characterized novel hepatoma‐specific promoters, which were valuable for cancer‐specific gene therapy, using HSV‐1 vectors. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4195405</comments>
            <pubDate>Mon, 22 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4195405</guid>        </item>
        <item>
            <title>Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery</title>
            <link>http://www.medworm.com/index.php?rid=4252322&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1538</link>
            <description>ConclusionsA new set of polymers with low toxicity and high stability was synthesized, which contains promising candidates for pulmonary gene transfer, as documented by in vivo experiments in mice. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4252322</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4252322</guid>        </item>
        <item>
            <title>Visualization of intracellular trafficking of Math1 protein in different cell types with a newly constructed non‐viral gene delivery plasmid</title>
            <link>http://www.medworm.com/index.php?rid=4248064&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1537</link>
            <description>ConclusionsThe newly constructed plasmid pcDNA6.2/C‐EmGFP‐Math1 was suitable for non‐viral gene delivery of Math1. Unique intracellular trafficking of Math1 with dynamics from the cytoplasm to the nucleus was demonstrated. The modification of MSCs by Math1 gene delivery and by BDNF and GDNF treatments can potentially be applied to cell replacement for the treatment of cochlear spiral ganglion cell loss in deafness. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4248064</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4248064</guid>        </item>
        <item>
            <title>Prophylactic, therapeutic and immune enhancement effect of LE‐PolyICLC on highly pathogenic H5N1 influenza infection</title>
            <link>http://www.medworm.com/index.php?rid=4240694&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1536</link>
            <description>ConclusionsTaken together, the data suggest that strong consideration should be given for the use of LE‐PolyICLC as prophylactic and therapeutic agents and also as a vaccination adjuvant to combat highly pathogenic influenza infection and its associated complications such as pulmonary fibrosis. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4240694</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4240694</guid>        </item>
        <item>
            <title>Transplantation of CTLA4Ig gene‐transduced adipose tissue‐derived mesenchymal stem cells reduce inflammatory immune response and improve Th1/Th2 balance in experimental autoimmune thyroiditis</title>
            <link>http://www.medworm.com/index.php?rid=4202257&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1531</link>
            <description>Conclusion:Although CTLA4Ig‐MSC transplantation had better result in reduction of serum TgAA, both of ATMSC and CTLA4Ig‐MSC transplantation is a promising treatment for autoimmune thyroiditis judging from the results of histopathology and cytokine analysis. They may be an attractive candidate for treating organ‐specific autoimmune disease. Copyright © 2010 John Wiley &amp; Sons, Ltd. (Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4202257</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4202257</guid>        </item>
        <item>
            <title>Conference Calendar</title>
            <link>http://www.medworm.com/index.php?rid=4195411&amp;cid=s_33648_50_f&amp;fid=33648&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjgm.1524</link>
            <description>(Source: The Journal of Gene Medicine)</description>
            <author>The Journal of Gene Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4195411</comments>
            <pubDate>Mon, 01 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4195411</guid>        </item>
    </channel>
</rss>

